New Molecular Entities Approved In 2014
This article was originally published in Pharmaceutical Approvals Monthly
Annual listing of novel drugs cleared by FDA’s Center for Drug Evaluation and Research.
You may also be interested in...
Years after a scathing Indian parliamentary report flagged concerns around regulatory lapses for drug approvals, an expert panel has endorsed the continued marketing of ambrisentan and everolimus in the country. But dronedarone, also featured in the report, is no longer sold by Sanofi in India.